In Vitro Activities of 15 Antimicrobial Agents against 110 Toxigenic Clostridium difficile Clinical Isolates Collected from 1983 to 2004 von HECHT, David W, GALANG, Minerva A, SAMBOL, Susan P, OSMOLSKI, James R, JOHNSON, Stuart, GERDING, Dale N

Volltext

Kibdelomycin Is a Potent and Selective Agent against Toxigenic Clostridium difficile von MIESEL, Lynn, HECHT, David W, LIU, Jenny, OLSEN, David B, SINGH, Sheo B, OSMOLSKI, James R, GERDING, Dale, FLATTERY, Amy, FANGBIAO LI, JING LAN, LIPARI, Philip, POLISHOOK, Jon D, LIANZHU LIANG

Volltext

Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Strain BI/NAP1/027 von Wieczorkiewicz, Jeffrey T, Lopansri, Bert K, Cheknis, Adam, Osmolski, James R, Hecht, David W, Gerding, Dale N, Johnson, Stuart

Volltext

Differences in the Molecular Epidemiology and Antibiotic Susceptibility of Clostridium difficile Isolates in Pediatric and Adult Patients von Kociolek, Larry K, Gerding, Dale N, Osmolski, James R, Patel, Sameer J, Snydman, David R, McDermott, Laura A, Hecht, David W

Volltext

Comparison of Activities of Trovafloxacin (CP-99,219) and Five Other Agents Against 585 Anaerobes with Use of Three Media von Hecht, David W., Osmolski, James R.

Volltext

Variation in the Susceptibility of Bacteroides fragilis Group Isolates from Six Chicago Hospitals von Hecht, David W., Osmolski, James R., O'Keefe, J. Paul

Volltext

Antibiotic Resistance Among Anaerobes: What Does it Mean? von Hecht, David W., Vedantam, Gayatri, Osmolski, James R.

Volltext